BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3114528)

  • 21. Characterization of a COS cell line deficient in polyamine transport.
    Hyvönen T; Seiler N; Persson L
    Biochim Biophys Acta; 1994 Apr; 1221(3):279-85. PubMed ID: 8167149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pretreatment with alpha-difluoromethylornithine on the selectivity of methylglyoxal bis(guanylhydrazone) for tumor tissue in L1210 leukemic mice.
    Kramer DL; Paul B; Porter CW
    Cancer Res; 1985 Jun; 45(6):2512-5. PubMed ID: 3921245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the tissue disposition of methylglyoxal bis(guanylhydrazone) in mice by polyamine depletion and by polyamine administration.
    Kallio A; Seppänen P; Alhonen-Hongisto L; Jänne J
    Cancer Res; 1983 Jan; 43(1):324-7. PubMed ID: 6401167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyamines increase in human peripheral blood and bone marrow mononuclear cells following administration of methylglyoxal bis(guanylhydrazone).
    Maddox AM; Keating MJ; Freireich EJ; Haddox MK
    Chemotherapy; 1988; 34(5):419-29. PubMed ID: 3141118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined use of 2-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) in normal and leukemia-bearing mice.
    Seppänen P; Alhonen-Hongisto L; Jänne J
    Cancer Lett; 1983 Feb; 18(1):1-10. PubMed ID: 6402294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difluoromethylornithine enhances the uptake of methylglyoxal-bis(guanylhydrazone) prior to inhibiting leukemic cell proliferation.
    Maddox AM; Orengo I; Haddox MK
    Chemotherapy; 1987; 33(2):110-22. PubMed ID: 3105968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic antileukemic effect of two polyamine synthesis inhibitors. Host survival and cell-cycle kinetic analysis.
    Ask A; Persson L; Oredsson SM; Heby O
    Int J Cancer; 1986 Mar; 37(3):465-70. PubMed ID: 3081454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy with inhibitors of polyamine biosynthesis in refractory prostatic carcinoma. An experimental and clinical study].
    Dunzendorfer U; Knöner M
    Onkologie; 1985 Aug; 8(4):196-200. PubMed ID: 2419811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyamine depletion-mediated effects on murine odontogenesis are dependent on tooth developmental stage and culture conditions.
    Gritli-Linde A; Ruch JV; Linde A
    Int J Dev Biol; 1995 Apr; 39(2):383-93. PubMed ID: 7669549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haematological cell proliferation and differentiation responses to perturbations of polyamine biosynthesis.
    O'Conor GT; McCann PP; Wharton WW; Niskanen E
    Cell Tissue Kinet; 1986 Sep; 19(5):539-46. PubMed ID: 3098430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of hyperthermochemotherapy for human gastric cancer in nude mice by thermosensitization with nitroimidazoles.
    Fujimoto S; Ohta M; Shrestha RD; Kokubun M; Miyoshi T; Mori T; Arimizu N; Okui K
    Br J Cancer; 1988 Jul; 58(1):42-5. PubMed ID: 3166892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antitumor effects of polyamine synthesis inhibitors based on major premise of treatment for human malignant tumor].
    Fujimoto S; Shrestha RD; Igarashi K; Terao K; Hirose S; Okui K
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1778-84. PubMed ID: 6820883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigrowth effect of some inhibitors of polyamine synthesis on transplantable prostate cancer.
    Dunzendorfer U; Relyea NM; Kleinert E; Balis ME; Whitmore WF
    Oncology; 1983; 40(1):57-62. PubMed ID: 6401860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of prostate carcinoma with polyamine synthesis inhibitors. I. Physiological and pathophysiological principles].
    Dunzendorfer U
    Urol Int; 1982; 37(5):349-57. PubMed ID: 6186061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in bone marrow and blood mononuclear cell polyamine and methylglyoxal bis(guanylhydrazone) levels: phase I evaluation of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) treatment of human hematological malignancies.
    Maddox AM; Freireich EJ; Keating MJ; Haddox MK
    Cancer Res; 1988 Mar; 48(5):1367-73. PubMed ID: 3124958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I study of alpha-difluoromethylornithine and methyl-GAG.
    Splinter TA; Romijn JC
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):61-7. PubMed ID: 3082642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Enhancement of hyperthermochemotherapy with hypoxic cell radiosensitizers].
    Ohta M; Fujimoto S; Shresta RD; Kokubun M; Kobayashi K; Kiuchi S; Miyoshi T; Arimatsu N; Mori T; Okui K
    Gan No Rinsho; 1988 Mar; 34(3):283-7. PubMed ID: 3128668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of X-ray-induced DNA strand break repair in polyamine-depleted HeLa cells.
    Snyder RD
    Int J Radiat Biol; 1989 May; 55(5):773-82. PubMed ID: 2565938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of DL-alpha-difluoromethylornithine, 4-deoxypyridoxine and methylglyoxal bis(guanylhydrazone) on allograft prolongation.
    Campbell RA; Kurtz GL; Norton-Reel DJ
    Life Sci; 1991; 48(3):225-35. PubMed ID: 1992280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
    Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W
    J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.